The management of postherpetic neuralgia with chlorprothixene.
Sixteen patients with established postherpetic pain were treated with chlorprothixene. Several other pain problems were simultaneously treated. Chlorprothixene was found to produce a favorable pain response in most patients with postherpetic pain while failing to be of value in other clinical pain problems. Chlorprothixene may be a satisfactory drug for the control of spinal or ophthalmic postherpetic pain.
D000208:Acute Disease; D000368:Aged; D002749:Chlorprothixene / Q000627:therapeutic use*; D003389:Cranial Nerve Diseases / Q000188:drug therapy; D005260:Female; D006561:Herpes Simplex / Q000150:complications*; D006801:Humans; D008297:Male; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology; D009882:Ophthalmic Nerve; D013118:Spinal Cord Diseases / Q000188:drug therapy
D002749:Chlorprothixene